Prostate-Specific Membrane Antigen PET/Computed Tomography
- 9 June 2025
- journal article
- review article
- Published by Elsevier in PET Clinics
- Vol. 20 (3) , 379-393
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate CancerJAMA Oncology, 2019
- Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2018
- Early dynamic imaging in 68Ga- PSMA-11 PET/CT allows discrimination of urinary bladder activity and prostate cancer lesionsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2016
- F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2016
- Biodistribution and radiation dosimetry of 68Ga-PSMA HBED CC—a PSMA specific probe for PET imaging of prostate cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2016
- See the unseen: Mesorectal lymph node metastases in prostate cancerThe Prostate, 2016
- Distribution of metastatic sites in patients with prostate cancer: A population‐based analysisThe Prostate, 2013
- Lymphatic spread of nodal metastases in high‐risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneumThe Prostate, 2011
- Natural History of Progression After PSA Elevation Following Radical ProstatectomyJAMA, 1999
- Metastatic patterns of prostatic cancer: Correlation between sites and number of organs involvedCancer, 1984